DOI: 10.1007/s00259-017-3649-9Pages: 915-917

The “reset button” revisited: why high activity 131I therapy of advanced differentiated thyroid cancer after dosimetry is advantageous for patients

1. University Hospital Marburg, Department of Nuclear Medicine

2. Oncology Institute of Southern Switzerland

3. University Hospital Würzburg, Department of Nuclear Medicine

4. Istituto Nazionale Tumori IRCCS Foundation, Department of Nuclear Medicine

5. LUNAM Université, Oniris, «AMaROC»

6. The Royal Marsden Hospital & Institute of Cancer Research

Correspondence to:
Frederik A. Verburg
Tel: +49-6421-5864267
Email: verburg@med.uni-marburg.de

Close

Abstract

This article is freely available, click here to access the full text/PDF

  • Accepted: Feb 7, 2017
  • Online: Feb 16, 2017

Article Tools

eanm
EJNMMI Ad